Market Capitalization (Millions $) |
876 |
Shares
Outstanding (Millions) |
97 |
Employees |
- |
Revenues (TTM) (Millions $) |
38 |
Net Income (TTM) (Millions $) |
-100 |
Cash Flow (TTM) (Millions $) |
-42 |
Capital Exp. (TTM) (Millions $) |
2 |
Tango Therapeutics Inc
Tango Therapeutics Inc is a biotechnology company that is focused on developing precise cancer therapies utilizing a next-generation approach. The company leverages the latest advancements in genomics and CRISPR screening technology to identify and target cancer vulnerabilities. Their platform aims to deliver personalized and precise treatments that can overcome drug resistance and improve patient outcomes. Tango Therapeutics Inc is dedicated to transforming the way cancer is treated by developing novel therapeutics that address the underlying genetic causes of the disease.
Company Address: 201 Brookline Ave. Boston 2215 MA
Company Phone Number: 320-4900 Stock Exchange / Ticker: NASDAQ TNGX
TNGX is expected to report next financial results on March 26, 2024. |
|
|